Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis

被引：0
|
作者：
Bizymi, N. [1 ]
Matthaiou, A. M. [1 ]
Stathakis, G. [1 ]
Viziriannaki, S. [1 ]
Bibaki, E. [1 ]
Tzanakis, N. [1 ]
Antoniou, K. [1 ]
机构：
[1] Univ Crete, Sch Med, Dept Resp Med, Iraklion, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Orphan diseases; Immunology; Pharmacology;
D O I：
10.1183/13993003.congress-2022.3774
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3774
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mepolizumab. Anti-IL-5 monoclonal antibody therapy in patients with Severe Eosinophilic Asthma
    Buttler, Bogna
    Dewor, Robert
    ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (03): : 137 - 142
  • [22] Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor α levels in patients with eosinophilic esophagitis
    Conus, Sebastien
    Straumann, Alex
    Simon, Hans-Uwe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 269 - 269
  • [23] MEPOLIZUMAB THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) - ONE YEAR FOLLOW-UP STUDY USING ANTI-IL5 AS A STEROID SPARING THERAPEUTIC APPROACH
    Egan, Allyson
    Sivasothy, Pasupathy
    Gore, Robin
    MartinezDel-Pero, Marcos
    Willcocks, Lisa
    Smith, Rona
    Burns, Stella
    Owen, Caroline
    Jones, Rachel B.
    Jayne, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 678 - 679
  • [24] Mepolizumab and Benralizumab: new therapeutic perspectives for Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
    Scarano, Paola
    Cisternino, Cecilia
    Lo Muzio, Giulia
    Calo, Olimpia
    Sanna, Arianna
    Steffanina, Alessia
    De Filippis, Francesca
    Leporini, Maria Teresa
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [25] EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS AND A VASCULITIC PHENOTYPE
    Terrier, B.
    Jayne, D.
    Hellmich, B.
    Bently, J. H.
    Steinfeld, J.
    Yancey, S. W.
    Kwon, N.
    Akuthota, P.
    Khoury, P.
    Baylis, L.
    Wechsler., M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 709 - 709
  • [26] EFFECTS OF MEPOLIZUMAB ON PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS IN THE UNITED STATES
    Silver, J.
    Corbridge, T.
    MacKnight, S.
    Urosevic, A.
    Martinez, C.
    Zhang, K.
    Laliberte, F.
    Deb, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S79 - S80
  • [27] Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis and a Vasculitic Phenotype
    Terrier, Benjamin
    Jayne, David
    Hellmich, Bernhard
    Bentley, Jane
    Steinfeld, Jonathan
    Yancey, Steven
    Kwon, Namhee
    Akuthota, Praveen
    Khoury, Paneez
    Baylis, Lee
    Wechsler, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2139 - 2141
  • [28] Low Dose Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Jackson, D. J.
    Green, L.
    Fernandes, M.
    Bolton, M.
    Roxas, C.
    D'Ancona, G.
    Agarwal, S.
    Kent, B. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] MEPOLIZUMAB FOR THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS.
    Smith, Rona
    RHEUMATOLOGY, 2017, 56 : 15 - 15
  • [30] Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
    Wechsler, Michael E.
    Nair, Parameswaran
    Terrier, Benjamin
    Walz, Bastian
    Bourdin, Arnaud
    Jayne, David R. W.
    Jackson, David J.
    Roufosse, Florence
    Boerjesson Sjoe, Lena
    Fan, Ying
    Jison, Maria
    Mccrae, Christopher
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    Merkel, Peter A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (10): : 911 - 921
12345